Chronic migraine as seen by neurologists and patients: Results of the CIEN-mig project (III);La migraña crónica vista por el neurólogo y el paciente: Resultados del proyecto CIEN-mig (III)

Revista de Neurologia

Volumn 50, Issue 12, 2010, Pages 705-710

  Pascual, Julio ^a   Sánchez Del Río, Margarita ^b   Dolores Jiménez, María ^c   Láinez Andrés, José Miguel ^d   Mateos, Valentín ^e   Leira, Rogelio ^f   Pozo Rosich, Patricia ^g   Guzmán Quilo, Carlos ^h  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL RUBER INTERNACIONAL   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e Centro Medico de Asturias   (Spain)

^f Instituto de Salud Carlos III   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h Departamento Médico   (Spain)

Author keywords

Analgesic overuse; Chronic migraine; Migraine; Preventive treatment

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CONSULTATION; DELAYED DIAGNOSIS; DRUG USE; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; RISK FACTOR; TRANSFORMED MIGRAINE;

EID: 77954416818     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5012.2010301     Document Type: Article

References (40)

1. Pascual J, Combarros O, Leno C, Polo JM, Rebollo M, Berciano J. Distribución por diagnósticos del dolor de cabeza como motivo de consulta neurológica. Med Clin (Barc) 1995; 104: 161-4.
2. Gracia-Naya M, Marta E, Usón M, Carod J. Un estudio descriptivo epidemiológico de una consulta de neurología ambulatoria. Rev Neurol 1996, 24: 633-7.
3. Gracia-Naya M, Usón-Martín MM. Estudio multicéntrico transversal de la asistencia neurológica ambulatoria en el sistema de salud español en Aragón: resultados globales. Rev Neurol 1997; 25: 194-9.
4. Gracia-Naya M. La importancia de las cefaleas en las consultas de neurología. Grupo de estudio de neurólogos aragoneses. Rev Neurol 1999; 29: 393-6.
5. Bueno V, Hernández M, Guerrero AL, Ponce MA, Ovejero A. Estudio epidemiológico prospectivo de la consulta externa en un servicio de neurología de la provincia de Palencia. Neurología 2000; 15: 388-92.
6. Gracia-Naya M; Grupo de Estudio de Neurólogos Aragoneses. Cefalea de tensión crónica en la consulta externa de neurología. Rev Neurol 2000; 31: 929-32.
7. González-Menacho J, Olivé Plana JM. Epidemiología de las enfermedades neurológicas ambulatorias en el Baix Camp. Neurologia 2001; 16: 154-62.
8. Guitera V, Muñoz P, Castillo J, Pascual J. Quality of life in chronic daily headache: a study in a general population. Neurology 2002; 58: 1062-5. (Pubitemid 34298546)
9. Colás R, Muñoz P, Temprano R, Gómez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004; 62: 1338-42. (Pubitemid 38526046)
10. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994; 34: 1-7. (Pubitemid 24038967)
11. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47: 871-5. (Pubitemid 26362016)
12. Guitera V, Muñoz P, Castillo J, Pascual J. Transformed migraine: a proposal for the modification of its diagnostic criteria based on recent epidemiological data. Cephalalgia 1999; 19: 847-50.
13. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 (Suppl 1): S9-160.
14. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26: 742-6.
15. Pascual J, Cacabelos P. More lessons for the treatment of chronic headache. J Headache Pain 2008; 9: 3-4.
16. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 2008; 71: 559-66.
17. Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005; 45 (Suppl 1): S3-13.
18. Bigal ME, Lipton RB. Concepts and mechanisms of migraine chronification. Headache 2008; 48: 7-15.
19. Bigal ME, Lipton RB. Clinical course in migraine: conceptualizing migraine transformation. Neurology 2008; 71: 848-55.
20. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48: 1157-68.
21. Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999; 39: 190-6. (Pubitemid 29190083)
22. Gracia-Naya M, Alarcia-Alejos R, Modrego-Pardo PJ. Importancia de la migraña crónica en una consulta general de neurología. Rev Neurol 2008; 46: 577-81.
23. Pascual J, Sánchez del Río M, Jiménez MD, Láinez JM, Matoes V, Leira R, et al. Actitud del neurólogo español frente a la migraña: resultados del proyecto CIEN-mig (I). Rev Neurol 2010; 50: 577-83.
24. Fontanillas N, Colás R, Muñoz P, Oterino A, Pascual J. Longterm evolution of chronic daily headache with medication overuse in the general population. Headache 2010 [in press].
25. Martínez JM, Calero S, García ML, Tranche S, Castillo J, Pérez I. Actitud de los médicos de atención primaria españoles ante la cefalea. Aten Primaria 2006; 38: 33-8.
26. Pascual J. Papel de los neuromoduladores en el tratamiento preventivo de la migraña. Rev Neurol 2009; 49: 25-32.
27. Pascual-Gómez J, Caminero AB, Cano A, Heras-Pérez JA, Leira-Muiño R, García-Ribas G, en nombre del grupo de investigadores participantes en el estudio PREVENTIA. Determinantes del uso de los fármacos con indicación para la profilaxis de la migraña en España. Rev Neurol 2007; 45: 513-8.
28. Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L. Topiramate in the treatment of chronic daily headache. Cephalalgia 2003; 23: 820-4.
29. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007; 47: 170-80.
30. Gracia-Naya M, Latorre-Jiménez AM, Ríos-Gómez C, Santos- Lasaosa S, Mauri-Llerda JA, Sánchez-Valiente S, et al. Topiramato en cefalea crónica diaria por migraña. Rev Neurol 2007; 45: 456-9.
31. Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brabdes J, et al. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache 2009; 49: 1153-62.
32. Diener HC, Agosti R, Allais S, Bergmans P, Bussone G, Davis B, et al. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2007; 6: 1054-62.
33. Pascual J, El Berdei Y, Gómez-Sánchez JC. How many migraine patients need prolonged (> 1 year) preventive treatment? Experience with topiramate. J Headache Pain 2007; 8: 90-3.
34. Pascual J, Leira R, Láinez JM. Combined therapy for migraine prevention? Clinical experience with a beta-blocker plus sodium valproate in 52 resistant migraine patients. Cephalalgia 2003; 23: 961-2.
35. Pascual J, Rivas MT, Leira R. Testing the combination beta-blocker plus topiramate in refractory migraine. Acta Neurol Scand 2007; 115: 81
36. Pascual J, Aguirre J, García-Moncó JC, Seijo M. Migraña y cefalea de tensión. In Mateos V, ed. Guías para el diagnóstico y tratamiento de las cefaleas. Barcelona: Prous; 2006. p. 37-66.
37. Silberstein SD, Lipton RB, Dodick D, Freitag FG, Ramadan N, Mathew N, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007; 47: 170-80.
38. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201 (TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007; 27: 814-23.
39. Hagen K, Albretsen C, Vilming ST, Salvensen R, Gronning M, Helde G, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 2009; 29: 221-32.
40. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl 7): S1-96.